Psoriasis Condition Center

Guselkumab for Moderate-to-severe Plaque Psoriasis in Systemic Treatment-naïve Patients

Guselkumab for Moderate-to-severe Plaque Psoriasis in Systemic Treatment-naïve Patients

In a new study, researchers compared the safety and efficacy of guselkumab, a fully human interleukin-23 antibody indicated for the systemic treatment of moderate-to-severe plaque psoriasis
EHR Design for Psoriasis Patients

EHR Design for Psoriasis Patients

Electronic health records (EHRs) are becoming increasingly common as part of routine care. EHRs are beneficial in optimizing patient-physician interaction
An Analysis of Ixekizumab Treatment Patterns, Utilization, and Costs Among Psoriasis Patients

An Analysis of Ixekizumab Treatment Patterns, Utilization, and Costs Among Psoriasis Patients

In a new paper, study researchers assessed ixekizumab treatment patterns, healthcare utilization, and costs among patients with psoriasis.
Available Topical and Oral Treatments for Pediatric Psoriasis

Available Topical and Oral Treatments for Pediatric Psoriasis

Psoriasis is a common disease among pediatric patients that can lead to diminished quality of life, including through disturbed sleep
Cardiovascular Risks Associated with Biologic Therapies to Treat Psoriasis

Cardiovascular Risks Associated with Biologic Therapies to Treat Psoriasis

A new study evaluated the risk of major cardiovascular events—including acute coronary syndrome, unstable angina, myocardial infarction, and stroke

Curated Journal Abstracts